company background image
A011000 logo

GeneOne Life Science KOSE:A011000 Stock Report

Last Price

₩2.70k

Market Cap

₩218.0b

7D

4.3%

1Y

-57.9%

Updated

27 Mar, 2024

Data

Company Financials

GeneOne Life Science, Inc.

KOSE:A011000 Stock Report

Market Cap: ₩218.0b

A011000 Stock Overview

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals.

A011000 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis


GeneOne Life Science, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeneOne Life Science
Historical stock prices
Current Share Price₩2,695.00
52 Week High₩7,100.00
52 Week Low₩2,260.00
Beta-1.87
1 Month Change6.73%
3 Month Change-5.11%
1 Year Change-57.89%
3 Year Change-65.45%
5 Year Change-11.83%
Change since IPO220.32%

Recent News & Updates

Recent updates

Is GeneOne Life Science (KRX:011000) Using Debt In A Risky Way?

Mar 20
Is GeneOne Life Science (KRX:011000) Using Debt In A Risky Way?

GeneOne Life Science (KRX:011000) Has Rewarded Shareholders With An Exceptional 855% Total Return On Their Investment

Jan 10
GeneOne Life Science (KRX:011000) Has Rewarded Shareholders With An Exceptional 855% Total Return On Their Investment

Shareholder Returns

A011000KR BiotechsKR Market
7D4.3%3.1%3.8%
1Y-57.9%23.4%13.0%

Return vs Industry: A011000 underperformed the KR Biotechs industry which returned 23.4% over the past year.

Return vs Market: A011000 underperformed the KR Market which returned 13% over the past year.

Price Volatility

Is A011000's price volatile compared to industry and market?
A011000 volatility
A011000 Average Weekly Movement7.9%
Biotechs Industry Average Movement7.9%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A011000 has not had significant price volatility in the past 3 months.

Volatility Over Time: A011000's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197675Young-Keun Parkhttps://www.genels.com

GeneOne Life Science, Inc., a biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals. Its small molecule pipeline comprises GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS-1200, which is Phase II clinical trial for treatment of COVID-19. The company’s nucleic acid vaccines include GLS-3000 mRNA under feasible study and GLS-5310 DNA under phase 2 stage for the treatment of SARS-CoV-2; GLS-5100 under pre-clinical stage for prevention of herpes zoster; and GLS-5140 under pre-clinical stage for the treatment of SFTS prophylaxis.

GeneOne Life Science, Inc. Fundamentals Summary

How do GeneOne Life Science's earnings and revenue compare to its market cap?
A011000 fundamental statistics
Market cap₩217.97b
Earnings (TTM)-₩52.62b
Revenue (TTM)₩37.29b

5.7x

P/S Ratio

-4.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A011000 income statement (TTM)
Revenue₩37.29b
Cost of Revenue₩46.60b
Gross Profit-₩9.30b
Other Expenses₩43.31b
Earnings-₩52.62b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-672.30
Gross Margin-24.94%
Net Profit Margin-141.09%
Debt/Equity Ratio2.0%

How did A011000 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.